Effect of FXBH on Serum Markers and HbA1c in Diabetic Rats

5.5 KB of tabular data from a study exploring the anti-diabetic effects of *Fraxinus xanthoxyloides* bark extract. The dataset includes results from in vitro enzyme inhibition assays and an in vivo rat study measuring body weight, blood glucose, and biochemical parameters like HbA1c, lipids, and liver enzymes. It was authored by Mashal Shahzadi and last updated on June 4, 2026.

Use Cases

• Modeling the relationship between plant extract dosage and blood glucose reduction based on in vivo results
• Comparing the inhibitory potency of different extract fractions against α-amylase and α-glucosidase enzymes
• Analyzing correlations between biochemical markers like HbA1c, cholesterol, and liver enzymes in a diabetic animal model

Strengths

• Specific quantitative results are provided, such as concentrations of gallic acid (3.29 µg/mg) and quercetin (6.4 µg/mg) in the extract.
• The experimental design is detailed, including five distinct treatment groups for the in vivo study.
• Data is shared under a permissive CC-BY-4.0 license, allowing for reuse and redistribution.

Limitations

• The dataset is very small at 5.5 KB, indicating limited scope.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for statistical modeling.

Provenance

Source

figshare

Collection Method

Data originates from laboratory experiments, including GC-MS/HPLC analysis, in vitro enzyme assays, and an in vivo study on alloxan-induced diabetic rats.

Freshness

Last updated 2026-06-04 17:27:11; freshness should be verified.